- In its recently reported second quarter of fiscal 2026, Vestis Corporation posted sales of US$659.44 million, swung from a US$27.83 million net loss to a US$2.6 million net income, and delivered basic and diluted earnings per share from continuing operations of US$0.02.
- Despite revenue slipping slightly and full‑year guidance calling for revenue growth from 2% decline to flat, Vestis lifted its outlook for adjusted EBITDA and free cash flow, pointing to operational gains such as productivity improvements, better on-time deliveries, and fewer customer complaints under its transformation plan.
- Next, we will examine how Vestis’ upgraded EBITDA and free cash flow guidance reshapes its existing investment narrative built on margin improvement.
Uncover the next big thing with 25 elite penny stocks that balance risk and reward.
Vestis Investment Narrative Recap
To own Vestis today, you have to believe its turnaround can translate operational fixes into durable margin and cash flow improvement, even if revenue stays flat to slightly down. The key short term catalyst is whether the transformation plan keeps lifting adjusted EBITDA and free cash flow. The biggest risk remains that customer churn and pricing pressure prevent revenue stabilization. This quarter’s results support the margin story but do not yet remove that demand risk.
The most relevant update is Vestis raising its full year 2026 adjusted EBITDA outlook to US$295 million to US$325 million and free cash flow guidance to US$120 million to US$150 million, while still expecting revenue to be flat to down 2%. For a thesis centered on margin repair and deleveraging, that improved profitability and cash generation guidance sits right at the heart of the near term investment case.
Yet, while improving EBITDA and cash flow are encouraging, investors should still be aware of how ongoing customer attrition and mix shifts could...
Read the full narrative on Vestis (it's free!)
Vestis' narrative projects $2.7 billion revenue and $87.4 million earnings by 2029. This requires fairly flat yearly revenue growth and a $134.8 million earnings increase from -$47.4 million today.
Uncover how Vestis' forecasts yield a $7.81 fair value, a 36% downside to its current price.
Exploring Other Perspectives
Before this earnings beat, the most optimistic analysts were banking on Vestis reaching about US$2.9 billion in revenue and roughly US$120 million in earnings, which is far more upbeat than the consensus view that focused on modest growth and gradual margin repair. This quarter’s stronger profitability and higher EBITDA and free cash flow guidance may either support that bullish path or force all sides to revisit assumptions about how quickly Vestis can overcome customer and pricing risks.
Explore another fair value estimate on Vestis - why the stock might be worth as much as 14% more than the current price!
Form Your Own Verdict
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your Vestis research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Vestis research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Vestis' overall financial health at a glance.
Seeking Other Investments?
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
- The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
- Capitalize on the AI infrastructure supercycle with our selection of the 42 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
- AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com